Suven Life Sciences Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹1 Cr 0% YoYSee revenue, profit and what management said. You are viewing Q1 FY22.
SL

Suven Life Sciences Ltd

Q1 FY22Healthcare Services

Suven Life Sciences Q1 FY22 earnings call: Revenue & Margins

Q1 FY22 investor presentation: what the company reported on revenue, margins and capex.

Based on Suven Life Sciences Ltd's Q1 FY22 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹335
Market cap₹9.7K Cr

Revenue & Sales Performance

See what Suven Life Sciences Ltd said on revenue & sales performance — free account, 30 seconds.

Profitability & Margins

See what Suven Life Sciences Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It focuses primarily on Suven Life Sciences' drug discovery and development pipelines in CNS therapies, clinical study statuses, and corporate overview without detailing capital expenditures or facility expansions.

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Suven Life Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Suven Life Sciences Ltd said on order book & pipeline — free account, 30 seconds.

Suven Life Sciences Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1 Cr, net loss ₹107 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Suven Life Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What is Suven Life Sciences Ltd share price analysis?

Suven Life Sciences Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹9,651 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Suven Life Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.